Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
03/2001
03/20/2001US6203580 Oxidative dyeing
03/20/2001CA2213111C Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient
03/20/2001CA2199128C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/15/2001WO2001018231A2 METHOD FOR PRODUCING (R) OR (S)-HYDROXY-η-BUTYROLACTONE
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase
03/15/2001WO2001017972A2 Novel herbicides
03/15/2001WO2001017962A1 Processes for the preparation of tricyclic amino alcohol derivatives
03/15/2001WO2000064905A3 Method for alpha metalation of a derivative which is heterocyclic, monocyclic or polycyclic and possesses at least one 5-atom heterocycle and is unsaturated or aromatic
03/15/2001WO2000053583A8 Inhibitors of protein tyrosine phosphatase
03/15/2001WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
03/15/2001WO2000013648B1 Method for the preparation of citalopram
03/15/2001WO1999065870A3 Sulfonamide inhibitors of aspartyl protease
03/15/2001DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties
03/15/2001DE19942961A1 Verfahren zur Herstellung von aromatischen Aminen unter Katalyse von Palladaphosphacyclobutanen A process for the preparation of aromatic amines with catalysis by Palladaphosphacyclobutanen
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/15/2001CA2383757A1 Processes for the preparation of tricyclic amino alcohol derivatives
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1083163A2 Catalytic method for the preparation of aromatic amines using a palladaphosphacyclobutane compound as catalyst
03/14/2001EP1082317A1 Method for producing phthalic anhydride by means of catalytic vapor-phase oxidation of o-xylol/naphthalene mixtures
03/14/2001EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
03/14/2001EP1082115A1 Heterocyclic cis cyclopropane derivatives as melatonergic agents
03/14/2001EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/14/2001EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
03/14/2001CN1287554A Novel optically active aminopentane derivative
03/14/2001CN1287504A Method for separating vaporous phthalic acid anhydride from a gas stream
03/13/2001US6201139 Isomerization of epoxyalkenes to 2,5-dihydrofurans
03/13/2001US6201138 Isomerization of epoxyalkenes to 2,5-dihydrofurans
03/13/2001US6201137 Process for purifying tetrahydrofurans used as starting material for polyether polyols
03/13/2001US6201135 Method for separating contaminants from 3-(2′-Acetoxy-Ethyl-Dihydro-2(3H)-Furanone
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001US6201016 Immunosuppressant as 5-lipoxygenase inhibitor and/or as platelet activating factor receptor antagonist
03/13/2001US6201013 Inosine monophosphate dehydrogenase (impdh) inhibitor; side effect reduction, non-drug resistant
03/13/2001US6200989 Administering as urokinase plasminogen activator antagonists, antitumor and antimetastasis agents
03/13/2001US6200353 Coupler for use in oxidative hair dyeing
03/08/2001WO2001016131A2 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
03/08/2001WO2001016126A2 Method for producing gamma-butyrolactone
03/08/2001WO2001016119A1 Hypoglycemic n,n-arylsulfonylglycine compounds
03/08/2001WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
03/08/2001WO2000058298A3 PROCESS FOR THE PREPARATION OF α-METHYLENELACTONES AND α-SUBSTITUTED HYDROCARBYLIDENE LACTONES
03/08/2001WO1999019296A8 Aminobutanoic acid derivatives
03/08/2001DE19941649A1 New fluorothiophene, furan, isoxazole, thiazole, cyclopentane, cyclopentene and alkylfluorothiophenecarboxylic acid compounds are useful in liquid crystals mixtures and synthesis of liquid crystals, agrochemicals and pharmaceuticals
03/08/2001DE19941595A1 Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen Use of fused benzene derivatives as antioxidant or free radical scavengers in cosmetic preparations
03/08/2001DE19941569A1 Verfahren zur Herstellung von gamma-Butyrolacton Process for the preparation of gamma-butyrolactone
03/08/2001DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl
03/07/2001EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof
03/07/2001EP1081124A2 Process for catalytic selective oxidation of a hydrocarbon substrate
03/07/2001EP1080779A2 Reactor for catalytic selective oxidation of a hydrocarbon substrate
03/07/2001EP1080716A1 Annelated benzene derivatives as antioxidants and radical scavengers in cosmetic preparations
03/07/2001EP1080085A1 Preparation of cis-6,6-dimethyl-3-oxa-bicyclo 3.1.0]hexan-2-one
03/07/2001EP1080082A1 Intermediates for the synthesis of epothilones and methods for their preparation
03/07/2001EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/07/2001EP1080066A1 Bioreductive cytotoxic agents
03/07/2001EP1080061A1 METHOD FOR PRODUCING MIXTURES OF 1,4-BUTANEDIOL, TETRAHYDROFURAN AND $g(g)-BUTYROLACTONE
03/07/2001EP1079821A1 Protease inhibitors
03/07/2001EP0934295B1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
03/07/2001CN1286688A Method for preparation of citalopram
03/07/2001CN1286687A Method for preparation of citalopram
03/07/2001CN1286254A Aromatic amino ether as analgesics
03/07/2001CN1286139A Improved catalyst for preparing 1,4-butanediol by hydrogenation of maleic acid
03/07/2001CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof
03/07/2001CN1062711C Pesticide and fungicide of unsaturated oximido ethers
03/06/2001US6197977 Lactonization of alkyl 2-keto-gulonate in acid
03/06/2001US6197817 Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
03/06/2001US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
03/06/2001US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/06/2001US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors
03/06/2001US6197767 Arglabin compounds and therapeutic uses thereof
03/06/2001US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents
03/01/2001WO2001014376A1 Novel spiro compounds
03/01/2001WO2001014359A1 Production of maleic anhydride
03/01/2001WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
03/01/2001WO2001014328A2 Substituted ureas as cell adhesion inhibitors
03/01/2001WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers
03/01/2001WO2001014308A1 Method for producing phthalic anhydride according to specifications
03/01/2001WO2001014303A1 Triketone compounds, process for producing the same and herbicides containing the same
03/01/2001WO2001013950A1 Percutaneous absorption agents
03/01/2001WO2000066577A3 Brigded cycloalkanes as thromboxane ligands without blood clotting effects
03/01/2001WO1999043314A9 Farnesyl-protein transferase inhibitors
03/01/2001CA2384511A1 Substituted chiral allosteric hemoglobin modifiers
03/01/2001CA2381468A1 Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders
02/2001
02/28/2001EP1078922A1 Process for the preparation of esters or lactones
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/28/2001EP1077973A2 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
02/28/2001EP1077970A1 11-aryl-benzo(b)naphtho(2,3-d)furans and 11-aryl-benzo(b)naphtho(2,3-d)thiophenes useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077969A1 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077968A1 Naphtho[2,3-b]heteroar-4-yl derivatives
02/28/2001EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077966A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077965A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
02/28/2001EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
02/28/2001EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001CN1285817A Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
02/28/2001CN1285352A Preparation for lignal like material
02/27/2001US6194590 Preparing substituted benzofuran-3-ones by reacting salicylic acid ether compound with strong base in inert gas and/or in presence of diluent; reacting benzofuranonecarboxyic acid ester with potassium hydroxide and then acid acid
02/27/2001US6194587 Reacting mixture of molecular oxygen containing gas n-butane in reactor at conditions effective for formation of maleic anhydride; scrubbing reaction gas mixture to recover maleic anhydride; separating liquid, adding n-butane and reacting
02/27/2001US6194575 Reacting 2-nitroimino-3,5-dimethyl-1,3, 5-triaza-cyclohexane derivative with urea in presence of diluent to form 1,3-di-substituted 2-nitroguanidine
02/27/2001US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions